Lockheed Martin Corporation vs Medtronic PLC — how do they compare? Lockheed Martin Corporation trades at $510.77 (market cap $117.48B), while Medtronic PLC trades at $82.79 (market cap $106.61B). The key difference: Lockheed Martin Corporation and Medtronic PLC are close in size by market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| LMT | MDT | |
|---|---|---|
Market Cap | $117.48B | $106.61B |
Sector | Industrials | Health |
52-Week High | $676.70 | $105.35 |
52-Week Low | $410.74 | $73.75 |
Enterprise Value | $136.28B | $125.36B |
Dividend Yield | 2.71% | 3.46% |
Signals from Pluang's Aura AI — not financial advice
Lockheed Martin (LMT) trades at $509.44, showing modest daily gains of 0.13%. The stock faces bearish technical signals with recent earnings misses in Q4 2025 and Q1 2026, though Q3 2025 exceeded expectations. Revenue growth remains steady, reaching $75.05B in 2025, while net margins have compressed to 6.38%. Analyst sentiment is strongly positive with 57% buy ratings and a $614 consensus target, supported by recent contract wins and new product launches like the PAC-3 ACE interceptor.
LMT offers defensive exposure to elevated defense spending with a $194B backlog, but faces execution risks from margin pressure and debt levels. The stock trades at a premium 24.6x P/E with technical weakness near support at $504. Upside depends on Q2 earnings beat and defense budget sustainability amid geopolitical tensions.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →